RUNX1 and acute myeloid leukemia: This high frequency was significantly higher than in patients with assumed sporadic AML and is in line with data from previous reports, as somatic alterations of RUNX1 were reported as the most common somatic mutation in patients with RUNX1-FPD (i.e., 36%) [36].